Literature, target and pipeline intelligence for biotech BD, VC and R&D teams — collected from PubMed, Open Targets and ClinicalTrials.gov, delivered as a QA-reviewed PDF.
Scientific research support only — not medical, investment, or regulatory advice.
From a focused literature brief to Target Pro and Orphan / VC due diligence. Founding pilot — 30% off for the first 3 engagements (scope fixed in contract).
Systematic PubMed search, PMID bundles, gap themes, executive brief + glossary.
Ranked targets, druggability, competitive pipeline, risk matrix, optional gene deep dives.
Rare disease target briefs and VC scientific DD memos. Express 48h option available.
Partner diligence before term sheet · indication & target landscape in one pack.
Scientific DD snapshot before IC · not a substitute for full expert review.
Literature sweep & target shortlist to kick off internal prioritization.
NSCLC and DMD anchor samples · QA PASS · sales previews (expanded on paid delivery).
Indication, targets, timeline
Scope & pricing locked
50% deposit · intake
PDF + glossary · QA PASS